Citation: | HOU Jingyi, WU Jiawei, CAO Lijuan. Gut microbiota-mediated therapeutic effect of Shengmai formula (SMF) on sepsis in mice[J]. Journal of China Pharmaceutical University, 2023, 54(2): 218-225. DOI: 10.11665/j.issn.1000-5048.2023022701 |
[1] |
. JAMA, 2016, 315(8): 775-787.
|
[2] |
Xie JF, Wang HL, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey[J]. Crit Care Med, 2020, 48(3): e209-e218.
|
[3] |
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990—2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211.
|
[4] |
Shappell C, Rhee C, Klompas M. Update on Sepsis epidemiology in the era of COVID-19[J]. Semin Respir Crit Care Med, 2023, 44(1): 173-184.
|
[5] |
Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock[J]. Lancet, 2018, 392(10141): 75-87.
|
[6] |
Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure[J]. Virulence, 2014, 5(1): 66-72.
|
[7] |
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis campaign: international guidelines for management of Sepsis and septic shock 2021[J]. Crit Care Med, 2021, 49(11): e1063-e1143.
|
[8] |
Zhang Y, Zhang L, Zhang Y, et al. YiQiFuMai Powder injection attenuates coronary artery ligation-induced heart failure through improving mitochondrial function via regulating ROS generation and CaMKII signaling pathways[J]. Front Pharmacol, 2019, 10: 381.
|
[9] |
Xie RF. Effects of early goal-directed therapy combined with Yiqi Fumai lyophilized powder on Pcv-aCO2 and ScvO2 in patients with septic shock[J]. Chin J Integr Tradit West Med (中国中西医结合杂志), 2016, 36(3): 306-309.
|
[10] |
Cheng C, Yu X. Research progress in Chinese herbal medicines for treatment of Sepsis: pharmacological action, phytochemistry, and pharmacokinetics[J]. Int J Mol Sci, 2021, 22(20): 11078.
|
[11] |
Pan XW, Xue LX, Zhang JZ, et al. Yiqifumai lyophilized injection attenuates Sepsis-induced acute lung injury in mice[J]. J Emerg Tradit Chin Med (中国中医急症), 2021, 30(7): 1129-1133, 1168.
|
[12] |
Lu J, Yu Y, Wang XJ, et al. Mechanism of Shengmai injection on anti-Sepsis and protective activities of intestinal mucosal barrier in mice[J]. Chin J Integr Med, 2022, 28(9): 817-822.
|
[13] |
Adelman MW, Woodworth MH, Langelier C, et al. The gut microbiome''s role in the development, maintenance, and outcomes of sepsis[J]. Crit Care, 2020, 24(1): 278.
|
[14] |
You Y, Luo L, You YY, et al. Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats[J]. Chin Med, 2020, 15: 114.
|
[15] |
Guo HH, Shen HR, Tang MZ, et al. Microbiota-derived short-chain fatty acids mediate the effects of Dengzhan Shengmai in ameliorating cerebral ischemia via the gut-brain axis[J]. J Ethnopharmacol, 2023, 306: 116158.
|
[16] |
Wang Y, Xu YY, Xu XW, et al. Ginkgo biloba extract ameliorates atherosclerosis via rebalancing gut flora and microbial metabolism[J]. Phytother Res, 2022, 36(6): 2463-2480.
|
[17] |
Zhang YY, Fan QL, Hou YL, et al. Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling[J]. Brain Behav Immun, 2022, 102: 11-22.
|
[18] |
Yuan YY, Liu SH, Ding XF, et al. Early intestinal microbiota changes in aged and adult mice with sepsis[J]. Front Cell Infect Microbiol, 2022, 12: 1061444.
|
[19] |
Peng YH, Wei JL, Jia XN, et al. Changes in the microbiota in different intestinal segments of mice with sepsis[J]. Front Cell Infect Microbiol, 2022, 12: 954347.
|
[20] |
Pan HB, Huo LX, Shen WY, et al. Study on the protective effect of berberine treatment on sepsis based on gut microbiota and metabolomic analysis[J]. Front Nutr, 2022, 9: 1049106.
|
[21] |
Lou XR, Xue JF, Shao RF, et al. Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances[J]. Front Immunol, 2022, 13: 1063543.
|
[22] |
Li JX, Chen YQ, Li R, et al. Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis[J]. Mol Ther, 2023, 31(4): 1017-1032.
|
[23] |
Kalra SJS, Shankar H, Mansoori N, et al. Antibiotic-resistant bacteria originating from the gut may modulate the mucosal immune response during sepsis and septic shock[J]. Drug Target Insights, 2022, 16: 81-87.
|
[24] |
Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness[J]. Crit Care Clin, 2016, 32(2): 203-212.
|
[25] |
Liu CH, Ju AC, Zhou DZ, et al. Simultaneous qualitative and quantitative analysis of multiple chemical constituents in YiQiFuMai injection by ultra-fast liquid chromatography coupled with ion trap time-of-flight mass spectrometry[J]. Molecules, 2016, 21(5): 640.
|
[26] |
Luo M, Yan DS, Sun QS, et al. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway[J]. J Cell Biochem, 2020, 121(4): 2994-3004.
|
[27] |
Ma R, Tian JH, Jiang J, et al. Inhibitory activities of ginsenosides on the activation of NLRP3 inflammasome[J]. J China Pharm Univ (中国药科大学学报), 2016, 47(5): 614-618.
|
[28] |
Guo LY, Hung TM, Bae KH, et al. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill[J]. Eur J Pharmacol, 2008, 591(1/2/3): 293-299.
|
[29] |
Sun HJ, Guo YK, Wang HD, et al. Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis[J]. Gut, 2023.
|
[30] |
Liu DC, Tian QQ, Liu KJ, et al. Ginsenoside Rg3 ameliorates DSS-induced colitis by inhibiting NLRP3 inflammasome activation and regulating microbial homeostasis[J]. J Agric Food Chem, 2023, 71(7):3472-3483.
|
[1] | ZHANG Dongxue, QIAO Liang. Microfluidic chip and mass spectrometry-based detection of bacterial antimicrobial resistance and study of antimicrobial resistance mechanism[J]. Journal of China Pharmaceutical University, 2023, 54(6): 695-705. DOI: 10.11665/j.issn.1000-5048.2023060203 |
[2] | LI Mengxiao, LI Huilin. Application of biological mass spectrometry in quality control of adeno-associated virus carrier preparations[J]. Journal of China Pharmaceutical University, 2023, 54(6): 682-694. DOI: 10.11665/j.issn.1000-5048.2023062901 |
[3] | WANG Maolin, GUO Weiwei, ZHENG Yueqin. Advances in fluorescence probes for detection of hydrogen polysulfides[J]. Journal of China Pharmaceutical University, 2023, 54(5): 553-563. DOI: 10.11665/j.issn.1000-5048.2023042804 |
[4] | LIU Lin, HU Tingting, WANG Mengling, NIE Yao, ZHANG Weijie, WANG Chen, ZOU Bingjie, SONG Qinxin, ZHOU Guohua. Advance on detection method and application based on bioluminescence of luciferase[J]. Journal of China Pharmaceutical University, 2023, 54(4): 389-398. DOI: 10.11665/j.issn.1000-5048.2023021401 |
[5] | WU Yubing, YIN Lifang, QIN Chao. Clinical application and detection of matrix metalloproteinases in diagnosis[J]. Journal of China Pharmaceutical University, 2020, 51(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20200514 |
[6] | SHEN Yiyun, QI Xiemin, SONG Qinxin, ZHOU Guohua. Research advances in quantitative detection of single cell protein[J]. Journal of China Pharmaceutical University, 2015, 46(5): 521-531. DOI: 10.11665/j.issn.1000-5048.20150502 |
[7] | ZHU Shenrong, WU Xuri, CHEN Yijun. Current progress in quantitative detection of microRNA[J]. Journal of China Pharmaceutical University, 2015, 46(1): 40-49. DOI: 10.11665/j.issn.1000-5048.20150104 |
[8] | Application Studies on Chromatographic Peak Purity with Photodiode-array Detection[J]. Journal of China Pharmaceutical University, 1993, (5): 290-294. |
[9] | An Experimental Study of Detecting HBcAg in Serum by ELISA[J]. Journal of China Pharmaceutical University, 1992, (3): 165-168. |
[10] | DETERMINATION OF PARACETAMOL IN RABBITS SERUM BY HPLC WITH ELECTRO-CHEMICAL DETECTION[J]. Journal of China Pharmaceutical University, 1987, (4): 290-292. |
1. |
杨婧雯,陈芊,单云龙,刘嘉莉,尉宁,王婧,王广基,周芳. 间充质干细胞产品及其外泌体在炎症性肠病治疗中的研究进展. 中国药科大学学报. 2024(01): 103-114 .
![]() | |
2. |
张强,罗曦,韩丽颖,王帅,包永睿,李天娇,孟宪生. 基于代谢组学研究hUC-MSCs-Exos联合复方木鸡颗粒抑制人肝癌细胞SMMC-7721增殖机制. 中华中医药杂志. 2024(10): 5481-5487 .
![]() |